nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CYP2C9—Capecitabine—esophageal cancer	0.0886	0.407	CbGbCtD
Brompheniramine—CYP2B6—Cisplatin—esophageal cancer	0.0844	0.388	CbGbCtD
Brompheniramine—CYP2C9—Cisplatin—esophageal cancer	0.0446	0.205	CbGbCtD
Brompheniramine—CHRM3—Signaling Pathways—GHRL—esophageal cancer	9.99e-05	0.000128	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GSTT1—esophageal cancer	9.99e-05	0.000128	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NOTCH3—esophageal cancer	9.9e-05	0.000126	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—GHRL—esophageal cancer	9.9e-05	0.000126	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—FBXW7—esophageal cancer	9.89e-05	0.000126	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CYP2A6—esophageal cancer	9.88e-05	0.000126	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—FBXW7—esophageal cancer	9.86e-05	0.000126	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.84e-05	0.000126	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—FBXW7—esophageal cancer	9.83e-05	0.000126	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CA2—esophageal cancer	9.82e-05	0.000125	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GAPDH—esophageal cancer	9.76e-05	0.000125	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—FBXW7—esophageal cancer	9.74e-05	0.000124	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GAPDH—esophageal cancer	9.68e-05	0.000124	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CRABP1—esophageal cancer	9.68e-05	0.000124	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CRABP1—esophageal cancer	9.59e-05	0.000123	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CYP1B1—esophageal cancer	9.4e-05	0.00012	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—HMOX1—esophageal cancer	9.38e-05	0.00012	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ALDH2—esophageal cancer	9.38e-05	0.00012	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS1—esophageal cancer	9.36e-05	0.00012	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ENO1—esophageal cancer	9.36e-05	0.00012	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PSME2—esophageal cancer	9.23e-05	0.000118	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PSME1—esophageal cancer	9.23e-05	0.000118	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CYP1B1—esophageal cancer	9.21e-05	0.000118	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GNG7—esophageal cancer	9.2e-05	0.000118	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HIF1A—esophageal cancer	9.16e-05	0.000117	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ADH7—esophageal cancer	9.13e-05	0.000117	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.13e-05	0.000117	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GNG7—esophageal cancer	9.12e-05	0.000117	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NOTCH2—esophageal cancer	9.02e-05	0.000115	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ABCB1—esophageal cancer	9e-05	0.000115	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NOTCH2—esophageal cancer	8.99e-05	0.000115	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NOTCH2—esophageal cancer	8.96e-05	0.000115	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GSTT1—esophageal cancer	8.92e-05	0.000114	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	8.88e-05	0.000113	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CYP19A1—esophageal cancer	8.84e-05	0.000113	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	8.82e-05	0.000113	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.78e-05	0.000112	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HIF1A—esophageal cancer	8.77e-05	0.000112	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—KDR—esophageal cancer	8.76e-05	0.000112	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CYP19A1—esophageal cancer	8.66e-05	0.000111	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ALDH2—esophageal cancer	8.62e-05	0.00011	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ALDH2—esophageal cancer	8.55e-05	0.000109	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—KDR—esophageal cancer	8.39e-05	0.000107	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ENO1—esophageal cancer	8.36e-05	0.000107	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS1—esophageal cancer	8.36e-05	0.000107	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NOTCH1—esophageal cancer	8.25e-05	0.000105	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PSME1—esophageal cancer	8.23e-05	0.000105	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PSME2—esophageal cancer	8.23e-05	0.000105	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GSTT1—esophageal cancer	8.2e-05	0.000105	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GSTT1—esophageal cancer	8.13e-05	0.000104	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	8.11e-05	0.000104	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—HMOX1—esophageal cancer	8.07e-05	0.000103	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.06e-05	0.000103	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	8.04e-05	0.000103	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.01e-05	0.000102	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ADH1B—esophageal cancer	8e-05	0.000102	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TGFBR2—esophageal cancer	8e-05	0.000102	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TGFBR2—esophageal cancer	7.98e-05	0.000102	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CYP1B1—esophageal cancer	7.96e-05	0.000102	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TGFBR2—esophageal cancer	7.95e-05	0.000102	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NOTCH1—esophageal cancer	7.9e-05	0.000101	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—HMOX1—esophageal cancer	7.9e-05	0.000101	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	7.87e-05	0.000101	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ABCB1—esophageal cancer	7.74e-05	9.9e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS1—esophageal cancer	7.69e-05	9.82e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ENO1—esophageal cancer	7.69e-05	9.82e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TYMP—esophageal cancer	7.65e-05	9.77e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ENO1—esophageal cancer	7.62e-05	9.74e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS1—esophageal cancer	7.62e-05	9.74e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ABCB1—esophageal cancer	7.58e-05	9.69e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SMAD4—esophageal cancer	7.57e-05	9.68e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PSME2—esophageal cancer	7.57e-05	9.68e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PSME1—esophageal cancer	7.57e-05	9.68e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SMAD4—esophageal cancer	7.55e-05	9.65e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SMAD4—esophageal cancer	7.53e-05	9.62e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PSME2—esophageal cancer	7.51e-05	9.6e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PSME1—esophageal cancer	7.51e-05	9.6e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CYP19A1—esophageal cancer	7.48e-05	9.57e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CREBBP—esophageal cancer	7.48e-05	9.56e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	7.45e-05	9.53e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.44e-05	9.51e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—EGFR—esophageal cancer	7.35e-05	9.4e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.25e-05	9.27e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.19e-05	9.19e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CREBBP—esophageal cancer	7.17e-05	9.16e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	7.11e-05	9.08e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—EGFR—esophageal cancer	7.04e-05	9e-05	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—PIK3CA—esophageal cancer	7.03e-05	8.98e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.92e-05	8.84e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TPI1—esophageal cancer	6.92e-05	8.84e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—HMOX1—esophageal cancer	6.83e-05	8.73e-05	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—PIK3CA—esophageal cancer	6.73e-05	8.6e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NOS3—esophageal cancer	6.7e-05	8.56e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.7e-05	8.56e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	6.68e-05	8.54e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.63e-05	8.47e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.56e-05	8.38e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ABCB1—esophageal cancer	6.56e-05	8.38e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	6.54e-05	8.35e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	6.48e-05	8.28e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NOS3—esophageal cancer	6.42e-05	8.2e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.38e-05	8.16e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—PIK3CA—esophageal cancer	6.38e-05	8.16e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.33e-05	8.08e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ERBB2—esophageal cancer	6.27e-05	8.01e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HIF1A—esophageal cancer	6.2e-05	7.92e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HIF1A—esophageal cancer	6.18e-05	7.9e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HIF1A—esophageal cancer	6.16e-05	7.87e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	6.14e-05	7.85e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—PIK3CA—esophageal cancer	6.11e-05	7.81e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	6.1e-05	7.79e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—HMOX1—esophageal cancer	6.1e-05	7.79e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	6.09e-05	7.79e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GNG7—esophageal cancer	6.02e-05	7.69e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CREBBP—esophageal cancer	6.02e-05	7.69e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ERBB2—esophageal cancer	6e-05	7.67e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.98e-05	7.64e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—KDR—esophageal cancer	5.93e-05	7.58e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—KDR—esophageal cancer	5.91e-05	7.55e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—KDR—esophageal cancer	5.89e-05	7.53e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ABCB1—esophageal cancer	5.85e-05	7.48e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—KDR—esophageal cancer	5.83e-05	7.45e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.64e-05	7.21e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—HMOX1—esophageal cancer	5.61e-05	7.17e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NOTCH1—esophageal cancer	5.58e-05	7.14e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NOTCH1—esophageal cancer	5.57e-05	7.11e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—HMOX1—esophageal cancer	5.56e-05	7.1e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NOTCH1—esophageal cancer	5.55e-05	7.09e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCND1—esophageal cancer	5.54e-05	7.08e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	5.49e-05	7.02e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.45e-05	6.97e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—NOS3—esophageal cancer	5.39e-05	6.88e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ABCB1—esophageal cancer	5.38e-05	6.88e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.36e-05	6.85e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CDKN1A—esophageal cancer	5.36e-05	6.85e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ABCB1—esophageal cancer	5.34e-05	6.82e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCND1—esophageal cancer	5.3e-05	6.78e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.3e-05	6.77e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CREBBP—esophageal cancer	5.18e-05	6.61e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CDKN1A—esophageal cancer	5.13e-05	6.56e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EP300—esophageal cancer	5.1e-05	6.51e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CREBBP—esophageal cancer	5.07e-05	6.48e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CREBBP—esophageal cancer	5.06e-05	6.47e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CREBBP—esophageal cancer	5.05e-05	6.45e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CREBBP—esophageal cancer	5.03e-05	6.43e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.03e-05	6.42e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ENO1—esophageal cancer	5.03e-05	6.42e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	4.98e-05	6.37e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—EGFR—esophageal cancer	4.97e-05	6.36e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	4.96e-05	6.34e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.96e-05	6.33e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PSME2—esophageal cancer	4.95e-05	6.33e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PSME1—esophageal cancer	4.95e-05	6.33e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—EGFR—esophageal cancer	4.94e-05	6.32e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTGS2—esophageal cancer	4.93e-05	6.3e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	4.89e-05	6.26e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EP300—esophageal cancer	4.88e-05	6.24e-05	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—PIK3CA—esophageal cancer	4.75e-05	6.08e-05	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	4.74e-05	6.06e-05	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—PIK3CA—esophageal cancer	4.72e-05	6.04e-05	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	4.68e-05	5.98e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—NOS3—esophageal cancer	4.63e-05	5.92e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—NOS3—esophageal cancer	4.54e-05	5.8e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NOS3—esophageal cancer	4.53e-05	5.79e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NOS3—esophageal cancer	4.52e-05	5.77e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NOS3—esophageal cancer	4.5e-05	5.76e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NOS3—esophageal cancer	4.46e-05	5.7e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MYC—esophageal cancer	4.44e-05	5.68e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.42e-05	5.65e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CREBBP—esophageal cancer	4.38e-05	5.6e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EGFR—esophageal cancer	4.34e-05	5.55e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—PIK3CA—esophageal cancer	4.32e-05	5.52e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	4.3e-05	5.5e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	4.29e-05	5.48e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.27e-05	5.46e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MYC—esophageal cancer	4.25e-05	5.44e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	4.25e-05	5.43e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ERBB2—esophageal cancer	4.24e-05	5.42e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTGS2—esophageal cancer	4.24e-05	5.42e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	4.23e-05	5.4e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	4.21e-05	5.38e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	4.17e-05	5.33e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EGFR—esophageal cancer	4.16e-05	5.32e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTGS2—esophageal cancer	4.15e-05	5.3e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—EP300—esophageal cancer	4.1e-05	5.24e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.03e-05	5.16e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.02e-05	5.13e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—NOS3—esophageal cancer	3.92e-05	5.01e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CREBBP—esophageal cancer	3.91e-05	5e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PIK3CA—esophageal cancer	3.77e-05	4.82e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCND1—esophageal cancer	3.75e-05	4.79e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCND1—esophageal cancer	3.73e-05	4.77e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCND1—esophageal cancer	3.72e-05	4.76e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCND1—esophageal cancer	3.69e-05	4.71e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.67e-05	4.69e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—esophageal cancer	3.65e-05	4.66e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN1A—esophageal cancer	3.62e-05	4.63e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	3.61e-05	4.62e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PIK3CA—esophageal cancer	3.61e-05	4.61e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	3.6e-05	4.6e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CREBBP—esophageal cancer	3.6e-05	4.6e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS2—esophageal cancer	3.59e-05	4.59e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.57e-05	4.56e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	3.57e-05	4.56e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—EP300—esophageal cancer	3.52e-05	4.5e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.52e-05	4.5e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—NOS3—esophageal cancer	3.5e-05	4.47e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—esophageal cancer	3.49e-05	4.46e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—EP300—esophageal cancer	3.45e-05	4.41e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EP300—esophageal cancer	3.45e-05	4.41e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EP300—esophageal cancer	3.44e-05	4.39e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EP300—esophageal cancer	3.43e-05	4.38e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EP300—esophageal cancer	3.39e-05	4.34e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—NOS3—esophageal cancer	3.22e-05	4.12e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS2—esophageal cancer	3.2e-05	4.09e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—NOS3—esophageal cancer	3.19e-05	4.08e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PIK3CA—esophageal cancer	3.03e-05	3.87e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MYC—esophageal cancer	3e-05	3.84e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MYC—esophageal cancer	2.99e-05	3.83e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MYC—esophageal cancer	2.99e-05	3.82e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—EP300—esophageal cancer	2.98e-05	3.81e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MYC—esophageal cancer	2.96e-05	3.78e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.95e-05	3.76e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EGFR—esophageal cancer	2.94e-05	3.76e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EGFR—esophageal cancer	2.93e-05	3.74e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.92e-05	3.73e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EGFR—esophageal cancer	2.92e-05	3.73e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EGFR—esophageal cancer	2.89e-05	3.7e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—EP300—esophageal cancer	2.66e-05	3.4e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CA—esophageal cancer	2.61e-05	3.33e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CA—esophageal cancer	2.55e-05	3.26e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CA—esophageal cancer	2.55e-05	3.26e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	2.54e-05	3.25e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	2.53e-05	3.24e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	2.51e-05	3.21e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—esophageal cancer	2.47e-05	3.15e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—esophageal cancer	2.46e-05	3.14e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—esophageal cancer	2.45e-05	3.13e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—EP300—esophageal cancer	2.45e-05	3.13e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—EP300—esophageal cancer	2.43e-05	3.1e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—esophageal cancer	2.43e-05	3.1e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.35e-05	3.01e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.21e-05	2.82e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NOS3—esophageal cancer	2.11e-05	2.69e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.97e-05	2.52e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.93e-05	2.46e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.81e-05	2.32e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.8e-05	2.3e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—EP300—esophageal cancer	1.6e-05	2.05e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.18e-05	1.51e-05	CbGpPWpGaD
